Monitoring strategies in adults eligible for pharmacological lipid-lowering therapy
OBJECTIVES: This is a protocol for a Cochrane review (intervention). The objectives are as follows: To assess the effects of different laboratory monitoring strategies for treatment efficacy (lipid levels) and treatment safety (hepatic, muscular, and renal parameters) in adults eligible for or receiving pharmacological lipid-lowering therapy for primary and/or secondary prevention of cardiovascular disease, including whether such monitoring is performed and the frequency or timing with which it is repeated.
Authors
- Juan Víctor Ariel Franco (ORCID: https://orcid.org/0000-0003-0411-899X)
- Kamyar Shokraee (ORCID: https://orcid.org/0000-0003-2828-2989)
- Nicole Skoetz (ORCID: https://orcid.org/0000-0003-4744-6192)
- Ana-Mihaela Zorger
- Eylul Taneri
- Brenda Bongaerts
- Camila Micaela Escobar Liquitay
- Siavosh Olfati (ORCID: https://orcid.org/0009-0008-2417-2145)
Institutions
- University of Cologne (DE)
- Hospital Italiano de Buenos Aires (AR)
- University Hospital Cologne (DE)
- Heinrich Heine University Düsseldorf (DE)
Publication Details
- Journal
- Cochrane Database of Systematic Reviews
- Published
- 2026-09-18
- DOI
- https://doi.org/10.1002/14651858.cd016386
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00